9p21 locus analysis in high‐risk gastrointestinal stromal tumors characterized for c‐kit and platelet‐derived growth factor receptor α gene alterations F Perrone, E Tamborini, GP Dagrada, F Colombo, L Bonadiman, ... Cancer 104 (1), 159-169, 2005 | 74 | 2005 |
Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis L Pandolfi, S Bozzini, V Frangipane, E Percivalle, A De Luigi, MB Violatto, ... Frontiers in immunology 12, 663303, 2021 | 56 | 2021 |
PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma MS Lagonigro, E Tamborini, T Negri, S Staurengo, GP Dagrada, F Miselli, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 54 | 2006 |
PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma MS Lagonigro, E Tamborini, T Negri, S Staurengo, GP Dagrada, F Miselli, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 54 | 2006 |
Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients E Gabanti, F Bruno, D Lilleri, C Fornara, P Zelini, I Cane, C Migotto, ... PLoS One 9 (8), e106044, 2014 | 50 | 2014 |
Reconstitution of Human Cytomegalovirus–Specific CD4+ T Cells is critical for control of virus reactivation in hematopoietic stem cell transplant recipients but does not … E Gabanti, D Lilleri, F Ripamonti, F Bruno, P Zelini, M Furione, ... Biology of Blood and Marrow Transplantation 21 (12), 2192-2202, 2015 | 48 | 2015 |
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors T Rampino, M Gregorini, G Bedino, G Piotti, E Gabanti, A Ibatici, ... Clinical science 120 (1), 25-36, 2011 | 42 | 2011 |
Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host G Gerna, D Lilleri, C Fornara, F Bruno, E Gabanti, I Cane, M Furione, ... Journal of General Virology 96 (2), 360-369, 2015 | 34 | 2015 |
KIT/Val654Ala receptor detected in one imatinib-resistant GIST patient E Tamborini, E Gabanti, MS Lagonigro, T Negri, S Pilotti, MA Pierotti, ... Cancer research 65 (3), 1115-1115, 2005 | 34 | 2005 |
Increased Erythrocyte Glutathione Peroxidase Activity and Serum Tumor Necrosis Factor-α in HIV-Infected Patients: Relationship to On-Going Prothrombotic State R Trotti, M Rondanelli, A Anesi, E Gabanti, R Brustia, L Minoli Journal of Hematotherapy & Stem Cell Research 11 (2), 369-375, 2002 | 26 | 2002 |
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study I Cassaniti, F Bergami, E Percivalle, E Gabanti, JC Sammartino, A Ferrari, ... Clinical Microbiology and Infection 28 (2), 301. e1-301. e8, 2022 | 25 | 2022 |
Human cytomegalovirus-specific T-cell reconstitution and late-onset cytomegalovirus infection in hematopoietic stem cell transplantation recipients following letermovir prophylaxis E Gabanti, O Borsani, AA Colombo, F Zavaglio, L Binaschi, D Caldera, ... Transplantation and Cellular Therapy 28 (4), 211. e1-211. e9, 2022 | 24 | 2022 |
Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection … D Lilleri, P Zelini, C Fornara, F Zavaglio, T Rampino, L Perez, E Gabanti, ... Journal of medical virology 90 (10), 1620-1628, 2018 | 21 | 2018 |
Mechanisms underlying sCD40 production in hemodialysis patients P Esposito, T Rampino, M Gregorini, E Gabanti, S Bianzina, A Dal Canton Cellular immunology 278 (1-2), 10-15, 2012 | 21 | 2012 |
Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis C Cereda, E Gabanti, M Corato, A De Silvestri, D Alimonti, E Cova, ... Amyotrophic Lateral Sclerosis 7 (4), 233-240, 2006 | 20 | 2006 |
Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic D Lilleri, F Zavaglio, E Gabanti, G Gerna, E Arbustini PLoS One 15 (11), e0242305, 2020 | 15 | 2020 |
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients D Lilleri, G Gerna, F Bruno, P Draghi, E Gabanti, C Fornara, F Meloni New Microbiol 36 (3), 267-277, 2013 | 14 | 2013 |
Robust and persistent B-and T-cell responses after COVID-19 in immunocompetent and solid organ transplant recipient patients F Zavaglio, V Frangipane, M Morosini, E Gabanti, P Zelini, JC Sammartino, ... Viruses 13 (11), 2261, 2021 | 12 | 2021 |
Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients E Gabanti, D Lilleri, L Scaramuzzi, P Zelini, T Rampino, G Gerna New Microbiol 41 (3), 195-202, 2018 | 12 | 2018 |
CD40/SCD40 imbalance in hemodialysis patients P Esposito, E Gabanti, S Bianzina, T Rampino, A Dal Canton Clinical biochemistry 44 (2-3), 268-269, 2011 | 12 | 2011 |